Skip to content

Seaport Therapeutics

US · SPTX #3277 by market cap Listed 2026
18.05 -0.27 -1.47%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:30

Price chart

After-hours 18.05 0.00%
27.8416.0818.052026-05-262026-11-20
MA5MA10MA20MA60
— MA5 — MA10 — MA20 — MA60
Reader sentiment Are you bullish or bearish on SPTX?

Anonymous reader poll. Unscientific, not investment advice.

✦ StockVane Quant Insights how this is computed

Quant Sentiment Neutral
  • Recent price momentum is -24.9% on average (3-month/1-year).
  • Main-fund capital flow has been a net inflow over the last 45 sessions.
  • Short interest has risen to 7.0% of float.
  • Analyst tilt is Buy.
Quant Technical Outlook Bearish
  • Price is below its 20-day average and below its 60-day average.
  • The 20-day average is below the 60-day average, a short-term downtrend.
Quant Rating, last 30 days C → C

Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.

Performance

1W -9.66%
1M -6.38%
3M -24.92%
6M +14.39%

Key statistics

Price & volume

Prev close
18.32
Open
18.02
Day range
17.41 - 18.83
Avg price
18.13
Volume
284.27K
Turnover
5.15M
Amplitude
7.77%
52-week range
14.85 - 28.38

Valuation

P/E
-12.78
P/E (TTM)
-6.97
P/B
2.43
EPS
-1.41
Net profit
-75.59M
Net assets
397.46M

Share structure

Market cap
966.23M
Float cap
334.46M
Shares out
53.53M
Float shares
18.53M

Dividend & listing

Dividend (TTM)
0.00
Listing date
2026-05-01
52-week range 24% of range
14.85 28.38

36.4% below the 52-week high

Trading activity

Net capital flow main funds, last 45 sessions

+363.97K net over the window

Short interest

Shares short
3.73M
As of
2026-10-30

Frequently asked questions

What is the current stock price of Seaport Therapeutics (SPTX)?

Seaport Therapeutics last traded at 18.05. This page shows a periodic quote snapshot. Check the displayed quote time.

What is Seaport Therapeutics's market cap?

About 966.23M.

What is the P/E ratio of Seaport Therapeutics?

The trailing twelve-month P/E is -6.97. The Valuation tab shows it against the stock's own five-year range.

Does Seaport Therapeutics pay a dividend?

Seaport Therapeutics does not currently pay a regular dividend.

Is Seaport Therapeutics a buy according to analysts?

The consensus of 7 analysts is a Buy rating, with an average 12-month price target of 37.43, which implies 107.4% upside from the current price. This is not investment advice.

What is Seaport Therapeutics's StockVane Quant Rating?

The StockVane Momentum strategy currently rates Seaport Therapeutics a C (Hold). Mid-pack momentum — held if you own it, not a fresh buy. Not investment advice.

Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.

Seaport Therapeutics discussion 0 comments

Add a comment